OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
RAMZ.PSX57

Rafhan Maize Products Co Ltd

Food ProcessingVerified

Rafhan Maize Products Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.69, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) of 22.41% and return on assets (ROA) of 11.04% are strong indicators of efficient capital utilization and asset management. These metrics suggest that the company is generating substantial returns relative to its equity and total assets, which is favorable compared to industry norms for food processing firms. The company's revenue is derived from a diversified set of segments, including food, pharmaceutical, industrial, and animal nutrition. While the exact revenue contribution from each segment is not disclosed, the broad product portfolio suggests a balanced exposure across different markets. The geographic exposure is primarily concentrated in Pakistan, with no significant international operations disclosed in the financial data. Looking ahead, the company's growth trajectory is supported by its strong profitability and operational cash flow. The operating cash flow of PKR 4.33 billion and free cash flow of PKR 743.23 million indicate the company's ability to fund operations and potentially reinvest in growth opportunities. However, the capital expenditure of PKR -2.6 billion suggests a reduction in investment in new projects or infrastructure, which may impact long-term growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after accounting for total debt, which could affect its ability to meet short-term obligations. The dilution risk is low, indicating that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core business of corn processing and has not disclosed any major new initiatives or strategic shifts in the latest financial data.

30-day price · RAMZ.PSX+662.88 (+7.5%)
Low$8700.00High$9776.00Close$9515.01As of15 May, 00:00 UTC
Profile
CompanyRafhan Maize Products Co Ltd
TickerRAMZ.PSX
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Rafhan Maize Products Co Ltd processes corn to produce food ingredients and industrial products, including food, pharmaceutical, industrial, and animal nutrition products.

Classification. Rafhan Maize Products Co Ltd is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

Rafhan Maize Products Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.69, suggesting it can cover its short-term obligations but with limited excess capacity. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) of 22.41% and return on assets (ROA) of 11.04% are strong indicators of efficient capital utilization and asset management. These metrics suggest that the company is generating substantial returns relative to its equity and total assets, which is favorable compared to industry norms for food processing firms. The company's revenue is derived from a diversified set of segments, including food, pharmaceutical, industrial, and animal nutrition. While the exact revenue contribution from each segment is not disclosed, the broad product portfolio suggests a balanced exposure across different markets. The geographic exposure is primarily concentrated in Pakistan, with no significant international operations disclosed in the financial data. Looking ahead, the company's growth trajectory is supported by its strong profitability and operational cash flow. The operating cash flow of PKR 4.33 billion and free cash flow of PKR 743.23 million indicate the company's ability to fund operations and potentially reinvest in growth opportunities. However, the capital expenditure of PKR -2.6 billion suggests a reduction in investment in new projects or infrastructure, which may impact long-term growth. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after accounting for total debt, which could affect its ability to meet short-term obligations. The dilution risk is low, indicating that the company is not expected to issue additional shares in the near term, which is a positive sign for existing shareholders. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core business of corn processing and has not disclosed any major new initiatives or strategic shifts in the latest financial data.
Key takeaways
  • Rafhan Maize Products Co Ltd has a strong return on equity (22.41%) and return on assets (11.04%), indicating efficient capital and asset utilization.
  • The company maintains a conservative debt-to-equity ratio of 0.3, suggesting a relatively low reliance on debt financing.
  • The company's liquidity position is characterized as medium, with a current ratio of 1.69, indicating it can cover its short-term obligations but with limited excess capacity.
  • The company's revenue is derived from a diversified set of segments, including food, pharmaceutical, industrial, and animal nutrition.
  • The company's growth trajectory is supported by its strong profitability and operational cash flow, but capital expenditure has decreased, which may impact long-term growth.
  • The company faces a medium liquidity risk and a low dilution risk, indicating a stable financial position for existing shareholders.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyPKR
Revenue$73.36B
Gross profit$13.81B
Operating income$11.51B
Net income$6.53B
R&D
SG&A
D&A
SBC
Operating cash flow$4.33B
CapEx-$2.60B
Free cash flow$743.2M
Total assets$59.17B
Total liabilities$30.01B
Total equity$29.17B
Cash & equivalents
Long-term debt$8.70B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$29.17B
Net cash-$8.70B
Current ratio1.7
Debt/Equity0.3
ROA11.0%
ROE22.4%
Cash conversion66.0%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
MetricRAMZ.PSXActivity
Op margin15.7%3.3% medp25 2.5% · p75 4.5%top quartile
Net margin8.9%3.0% medp25 1.5% · p75 6.7%top quartile
Gross margin18.8%24.0% medp25 20.2% · p75 35.3%bottom quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-3.5%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity30.0%33.5% medp25 29.1% · p75 81.5%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 14:29 UTC#5036d9ac
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 14:31 UTCJob: 8ce11dc0